Cardiomyocyte mitochondrial oxidative stress and cytoskeletal breakdown in the heart with a primary volume overload

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 308, Issue 6, 2015, Pages H651-H663

  Yancey, Danielle M ^b,c   Guichard, Jason L ^b,c   Ahmed, Mustafa I ^b,c   Zhou, Lufang ^b,c   Murphy, Michael P ^f   Johnson, Michelle S ^d,e   Benavides, Gloria A ^d,e   Collawn, James ^g   Darleyusmar, Victor ^d,e   Dell’Italia, Louis J ^a,b,c  

^a BIRMINGHAM VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cardiomyocyte; Heart failure; Mitochondria

Indexed keywords

BETA TUBULIN; BETA2 TUBULIN; CYTOCHROME C OXIDASE; DESMIN; DICHLORODIHYDROFLUORESCEIN DIACETATE; MITOUBIQUINONE; TETRAMETHYLRHODAMINE; UBIQUINONE; UNCLASSIFIED DRUG; ANTIOXIDANT; REACTIVE OXYGEN METABOLITE; TUBULIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTOCAVAL FISTULA; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; HEART LEFT VENTRICLE FUNCTION; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART VENTRICLE OVERLOAD; HEART VOLUME; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION SWELLING; MORPHOMETRICS; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; TRANSMISSION ELECTRON MICROSCOPY; ANALOGS AND DERIVATIVES; ANIMAL; DISEASE MODEL; DRUG EFFECTS; HEART CONTRACTION; HEART FAILURE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME; ULTRASTRUCTURE;

ANIMALS; ANTIOXIDANTS; CYTOSKELETON; DESMIN; DISEASE MODELS, ANIMAL; HEART FAILURE; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA, HEART; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; TIME FACTORS; TUBULIN; UBIQUINONE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84937395129     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00638.2014     Document Type: Article

References (48)

1. Agnetti G, Halperin VL, Kirk JA, Chakir K, Guo Y, Lund L, Nicolini F, Gherli T, Guarnieri C, Caldarera CM, Tomaselli GF, Kass DA, Van Eyk JE. Desmin modifications associate with amyloid-like oligomers deposition in heart failure. Cardiovasc Res 102: 24-34, 2014.
2. Ahmed MI, Gladden JD, Litovsky SH, Lloyd SG, Gupta H, Inusah S, Denney T, Powell P, McGiffin DC, Dell'Italia LJ. Increased oxidative stress and cardiomyocyte myofibrillar degeneration in patients with chronic isolated mitral regurgitation and ejection fraction > 60%. J Am Coll Cardiol 55: 671-679, 2010.
3. Appaix F, Kuznetsov AV, Usson Y, Kay L, Andrienko T, Olivares J, Kaambre T, Sikk P, Margreiter R, Saks V. Possible role of cytoskeleton in intracellular arrangement and regulation of mitochondria. Exp Physiol 88: 175-190, 2003.
4. Barnes J, Dell'Italia LJ. The multiple mechanistic faces of a pure volume overload: implications for therapy. Am J Med Sci 348: 337-346, 2014.
5. Borer JS, Bonow RO. Contemporary approach to aortic and mitral regurgitation. Circulation 108: 2432-2438, 2003.
6. Capetanaki Y. Desmin cytoskeleton: a potential regulator of muscle mitochondrial behavior and function. Trends Cardiovasc Med 12: 339- 348, 2002.
7. Carabello BA. The management of functional mitral regurgitation. Curr Cardiol Rep 9: 112-117, 2007.
8. Chacko BK, Srivastava A, Johnson MS, Benavides GA, Chang MJ, Ye Y, Jhala N, Murphy MP, Kalyanaraman B, Darley-Usmar VM. Mitochondria-targeted ubiquinone (MitoQ) decreases ethanol-dependent micro and macro hepatosteatosis. Hepatology 54L 153-163, 2011.
9. Chen YW, Pat B, Gladden JD, Zheng J, Powell P, Wei CC, Cui X, Husain A, Dell'Italia LJ. Dynamic molecular and histopathological changes in the extracellular matrix and inflammation in the transition to heart failure in isolated volume overload. Am J Physiol Heart Circ Physiol 300: H2251-H2260, 2011.
10. Collins JF, Pawloski-Dahm C, Davis MG, Ball N, Dorn GW 2nd, Walsh RA. The role of the cytoskeleton in left ventricular pressure overload hypertrophy and failure. J Mol Cell Cardiol 28: 1435-1443, 1996.
11. Cooper G 4th. Cytoskeletal networks and the regulation of cardiac contractility: microtubules, hypertrophy, and cardiac dysfunction. Am J Physiol Heart Circ Physiol 291: H1003-H1014, 2006.
12. Dalakas MC, Park KY, Semino-Mora C, Lee HS, Sivakumar K, Goldfarb LG. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutation of the desmin gene. N Engl J Med 342: 770-780, 2000.
13. Di Somma S, Di Benedetto MP, Salvatore G, Agozzino L, Ferranti F, Esposito C, La Dogana P, Scarano MI, Caputo G, Cotrufo M, De Santoe ML, de Divitiis O. Desmin-free cardiomyocytes and myocardial dysfunction in end stage heart failure. Eur J Heart Fail 6: 389 -398, 2004.
14. Enriquez-Sarano M, Sundt TM 3rd. Early surgery is recommended for mitral regurgitation. Circulation 121: 804-811, 2010.
15. Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, McGoon MD, Bailey KR, Frye RL. Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications. J Am Coll Cardiol 24: 1536 -1543, 1994.
16. Fetterman JL, Zelickson BR, Johnson LW, Moellering DR, Westbrook DG, Pompilius M, Sammy MJ, Salman ED, Johnson M, Dunham- Snary KJ, Cao X, Bradley WE, Zhang J, Wei CC, Chacko B, Schurr TG, Kesterson RA, Dell'Italia LJ, Darley-Usmar VM, Welch DM, Ballinger SW. Mitochondrial genetic background modulates bioenergetics and susceptibility to acute cardiac volume overload. Biochem J 455: 157-167, 2013.
17. Gillam LD, Schwartz A. Primum non nocere: the case for watchful waiting in asymptomatic "severe" degenerative mitral regurgitation. Circulation 121: 813-821, 2010.
18. Gladden JD, Zelickson BR, Guichard JL, Yancey DM, Ballinger S, Babu GJ, Darley-Usmar V, Dell'Italia LJ. Xanthine oxidase inhibition preserves left ventricular systolic but not diastolic function in cardiac volume overload. Am J Physiol Heart Circ Physiol 305: H1440-H1450, 2013.
19. Gladden JD, Zelickson BR, Wei CC, Ulasova E, Zheng J, Ahmed MI, Chen Y, Bamman M, Ballinger S, Darley-Usmar V, Dell'Italia LJ. Novel insights into interactions between mitochondria and xanthine oxidase in acute cardiac volume overload. Free Radic Biol Med 51: 1975- 1984, 2011.
20. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 56: 56-64, 1975.
21. Guzun R, Karu-Varikmaa M, Gonzalez-Granillo M, Kuznetsov AV, Michel L, Cottet-Rousselle C, Saaremäe M, Kaambre T, Metsis M, Grimm M, Auffray C, Saks V. Mitochondria-cytoskeleton interaction: distribution of β-tubulins in cardiomyocytes and HL-1 cells. Biochim Biophys Acta 1807: 458-469, 2011.
22. Hill B, Benavides G, Lancaster J, Ballinger S, Dell'Italia LJ, Zhang J, Darley-Usmar VM. Integration of cellular bioenergetics with mitochondrial quality control and autophagy. Biol Chem 393: 1485-1512, 2012.
23. Hutchinson KR, Guggilam A, Cismowski MJ, Galantowicz ML, West TA, Stewart JA Jr, Zhang X, Lord KC, Lucchesi PA. Temporal pattern of left ventricular structural and functional remodeling following reversal of volume overload heart failure. J Appl Physiol 111: 1778 -1788, 2011.
24. Kuznetsov AV, Javadov S, Guzun R, Grimm M, Saks V. Cytoskeleton and regulation of mitochondrial function: the role of β-tubulin II. Front Physiol 4: 1-6, 2013.
25. Li Z, Colucci-Guyon E, Pincon-Raymond M, Mericskay M, Pournin S, Paulin D, Babinet C. Cardiac lesions and skeletal myopathy in mice lacking desmin. Dev Biol 175: 362-366, 1996.
26. McClendon PL, Robbins J. Desmin-related cardiomyopathy: an unfolding story. Am J Physiol Heart Circ Physiol 301: H1220-H1228, 2011.
27. Milner DJ, Mavroidis M, Weisleder N, Capetanaki Y. Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function. J Cell Biol 150: 1283-1298, 2000.
28. Milner DJ, Weitzer G, Tran D, Bradley A, Capetanaki Y. Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. J Cell Biol 134: 1255-1270, 1996.
29. Monreal G, Nicholson LM, Han B, Joshi MS, Phillips AB, Wold LE, Bauer JA, Gerhardt MA. Cytoskeletal remodeling of desmin is a more accurate measure of cardiac dysfunction than fibrosis or myocyte hypertrophy. Life Sci 83: 786-794, 2008.
30. Nishimura RA, Otto CM, Bonow RO, Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Creager MA, Curtis LH, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Stevenson WG, Yancy CW; American College of Cardiology; American College of Cardiology/American Heart Association; American Heart Association. 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129: 2440-2492, 2014.
31. Panagopoulou P, Davos CH, Milner DJ, Varela E, Cameron J, Mann DL, Capetanaki Y. Desmin mediates TNF-α-induced aggregate formation and intercalated disk reorganization in heart failure. J Cell Biol 181: 761-775, 2008.
32. Pawlak A, Gil J, Walczak E, Seweryniak P. Desmin expression in human cardiomyocytes and clinical and echocardiographic parameters in patients with chronic heart failure. Kardiol Pol 67: 955-961, 2009.
33. Pawlak A, Gil RJ, Walczak E, Słysz A. Cardiomyocyte desmin abnormalities-an accurate predictor of long-term survival in patients with chronic heart failure. Kardiol Pol 67: 724 -233, 2006.
34. Reily C, Mitchell T, Chacko B, Benavides G, Murphy MP, Darley- Usmar V. Mitochondrially targeted compounds and their impact on cellular bioenergetics. Redox Biol 1: 86-93, 2013.
35. Ryan TD, Rothstein EC, Aban I, Tallaj JA, Husain A, Lucchesi PA, Dell'Italia LJ. Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload. J Am Coll Cardiol 49: 811-821, 2007.
36. Saks V, Guzun R, Timohhina N, Tepp K, Varikmaa M, Monge C, Beraud N, Kaambre T, Kuznetsov A, Kadaja L, Eimre M, Seppet E. Structure-function relationships in feedback regulation of energy fluxes in vivo in health and disease: mitochondrial interactosome. Biochim Biophys Acta 1797: 678-697, 2010.
37. Schiros CG, Dell'Italia LJ, Gladden JD, Clark D 3rd, Aban I, Gupta H, Lloyd SG, McGiffin DC, Perry G, Denney TS Jr, Ahmed MI. Magnetic resonance imaging with three-dimensional analysis reveals important left ventricular remodeling in isolated mitral regurgitation: implications beyond dimensions. Circulation 125: 2334 - 2342, 2012.
38. Schröder R, Kunz WS, Rouan F, Pfendner E, Tolksdorf K, Kappes- Horn K, Altenschmidt-Mehring M, Knoblich R, van der Ven PF, Reimann J, Fürst DO, Blümcke I, Vielhaber S, Zillikens D, Eming S, Klockgether T, Uitto J, Wiche G, Rolfs A. Disorganization of the desmin cytoskeleton and mitochondrial dysfunction in plectin-related epidermolysis bullosa simplex with muscular dystrophy. J Neuropathol Exp Neurol 61: 520-530, 2002.
39. Smith RA, Murphy MP. Animal and human studies with the mitochondria- targeted antioxidant MitoQ. Ann NY Acad Sci 1201: 96 -103, 2010.
40. Tagawa H, Koide M, Zile MR, Carabello BA, Cooper G. Cytoskeletal role in the transition from compensated to decompensated hypertrophy during adult canine left ventricular pressure overloading. Circ Res 82: 751-761, 1998.
41. Tsutsui H, Ishihara K, Cooper G. Cytoskeletal for contractile dysfunction of hypertrophied myocardium. Science 260: 682-687, 1993.
42. Ulasova E, Gladden JD, Chen Y, Zheng J, Pat B, Bradley W, Powell P, Zmijewski JW, Zelickson BR, Ballinger SW, Darley- Usmar V, Dell'Italia LJ. Loss of interstitial collagen causes structural and functional alterations of cardiomyocyte subsarcolemmal mitochondria in acute volume overload. J Mol Cell Cardiol 50: 147-156, 2011.
43. Wang X, Li F, Campbell SE, Gerdes AM. Chronic pressure overload cardiac hypertrophy and failure in guinea pigs: cytoskeletal remodeling. J Mol Cell Cardiol 31: 319-331, 1999.
44. Wang X, Osinska H, Klevitsky R, Gerdes AM, Nieman M, Lorenz J, Hewett T, Robbins J. Expression of R120G-αβ-crystallin causes aberrant desmin and αβ-crystallin aggregation and cardiomyopathy in mice. Circ Res 89: 84-91, 2001.
45. Wei CC, Chen Y, Powell LC, Zheng J, Shi K, Bradley WE, Powell PC, Ahmad S, Ferrario CM, Dell'Italia LJ. Cardiac kallikrein-kinin system is upregulated in chronic volume overload and mediates an inflammatory induced collagen loss. PLos One 7: e40110, 2012.
46. Zheng J, Chen Y, MD, Pat B, Dell'Italia LA, Tillson M, Dillon AR, Powell P, Shi K, Shah N, Denney T, Husain A, Dell'Italia LJ. Microarray identifies extensive downregulation of noncollagen extracellular matrix and profibrotic growth factor genes in chronic isolated MR in the dog. Circulation 119: 2086-2095, 2009.
47. Zile MR, Koide M, Sato H, Ishiguro Y, Conrad CH, Buckley JM, Morgan JP, Cooper 4th G. Role of microtubules in the contractile dysfunction of hypertrophied myocardium. J Am Coll Cardiol 33: 250- 260, 1999.
48. Zile MR, Green GR, Schuyler GT, Aurigemma GP, Miller DC, Cooper G 4th. Cardiocyte cytoskeleton in patients with left ventricular pressure overload hypertrophy. J Am Coll Cardiol 37: 1080 -1084, 2001.